QUE Oncology
Manufacturing · Georgia, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2870 Peachtree Rd NW 466, Atlanta, Georg...Website
www.queoncology.comRevenue
$5.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About QUE Oncology
QUE Oncology is focused on developing innovative non-hormonal therapies aimed at alleviating moderate to severe vasomotor symptoms in postmenopausal women and cancer patients undergoing hormone therapy. The company is dedicated to addressing the specific needs of these patient populations. Their product, Q-122, is part of their commitment to improving quality of life for individuals affected by these symptoms. QUE Oncology aims to provide effective solutions for women experiencing challenges related to hormonal changes.Explore more
QUE Oncology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is QUE Oncology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at QUE Oncology
QUE Oncology, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if QUE Oncology is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once QUE Oncology has new funding data
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on QUE Oncology recently announced quarterly report
Click to see if QUE Oncology had a recent Job posting/layoffs
Check if QUE Oncology has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when QUE Oncology launches new products
Recommended Actions
Find VP level buyers at QUE Oncology
Find more new buyers
Compare Similar Companies to QUE Oncology
Compare insights from companies similar to QUE Oncology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
QUE Oncology is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
QUE Oncology is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about QUE Oncology.
QUE Oncology financials insights
Gather financial insights about QUE Oncology, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Series A
$16M
QUE Oncology Tech Stack
A closer look at the technologies used by QUE Oncology
See more technologies
QUE Oncology News & Media
QUE Oncology Launches Phase II Trials in the United States
ATLANTA--(BUSINESS WIRE)--Clinical stage biotechnology company QUE Oncology today announces the launch of its Phase II trials which will see its novel non-hormonal therapy, for women with breast cancer suffering hot flashes and night sweats, tested at key sites in the United States. QUE Oncology is developing drugs for large unmet medical needs and has already advanced clinical development of its lead drug program Q-122, through four Phase 1 trials. QUE Oncology is now set to
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding QUE Oncology
Sign Up For FreeTo access detailed company insights
QUE Oncology is focused on developing innovative non-hormonal therapies aimed at alleviating moderate to severe vasomotor symptoms in postmenopausal women and cancer patients undergoing hormone therapy. The company is dedicated to addressing the specific needs of these patient populations. Their product, Q-122, is part of their commitment to improv... Read More
